Related Experiment Video
Updated: Jun 14, 2026

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic
Ritu Aneja1, Tohru Miyagi, Prasanthi Karna
1Department of Biology, Georgia State University, Atlanta, GA 30303, USA. raneja@gsu.edu
Abstract:
Hormone-refractory prostate cancer, its skeletal metastasis and complications remain a therapeutic challenge. Here we show that treatment with (S)-3-((R)-9-bromo-4-methoxy-6-methyl-5,6,7,8-tetrahydro-[1,3]dioxolo[4,5-g]isoquinolin-5-yl)-6,7-dimethoxyiso-benzofuran-1(3H)-one (EM011), the brominated analogue of a plant-derived non-toxic antitussive alkaloid, noscapine, achieved significant inhibition of hormone-refractory human prostate cancer implanted intratibially in the bone as shown by non-invasive, real-time bioluminescent imaging of tumour growth in nude mice. Mechanistically, in vitro data suggested that the antiproliferative and proapoptotic effects of EM011 in human prostate cancer cell lines were through blockade of cell-cycle progression by impairing the formation of a bipolar spindle apparatus. The G2/M arrest was accompanied by activation of the mitotic checkpoint, a pre-requisite for induction of optimal apoptosis. Attenuation of mitotic checkpoint by siRNA duplexes led to a reduction in mitotic arrest and subsequent apoptosis. Our results further demonstrated participation of an intrinsic mitochondrially mediated apoptotic pathway that ultimately triggered caspase-driven EM011-induced apoptosis. EM011 did not exert any detectable toxicity in normal tissues with frequently dividing cells such as the gut and bone marrow. Thus, these data warrant further evaluation of EM011 for the management of prostate cancer.
Insights
The novel compound EM011, a noscapine analogue, effectively inhibited hormone-refractory prostate cancer bone metastasis in mice. EM011 induced cancer cell death by disrupting cell division and activating apoptosis, with no observed toxicity in normal tissues.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Hormone-refractory prostate cancer with skeletal metastasis presents significant therapeutic challenges.
- Existing treatments often have limited efficacy and considerable side effects.
Purpose of the Study:
- To evaluate the efficacy of EM011, a novel brominated analogue of noscapine, against hormone-refractory prostate cancer.
- To elucidate the mechanism of action of EM011 in prostate cancer cells.
Main Methods:
- Treatment of intratibially implanted human prostate cancer in nude mice with EM011.
- Non-invasive, real-time bioluminescent imaging to monitor tumor growth.
- In vitro studies using human prostate cancer cell lines to assess antiproliferative and proapoptotic effects.
- siRNA-mediated attenuation of the mitotic checkpoint.
- Analysis of apoptotic pathways, including mitochondrial and caspase activation.
Main Results:
- EM011 significantly inhibited hormone-refractory prostate cancer growth in bone.
- EM011 induced G2/M cell-cycle arrest by impairing spindle apparatus formation, activating the mitotic checkpoint.
- Mitotic checkpoint activation was crucial for EM011-induced apoptosis.
- EM011 triggered an intrinsic, mitochondrially mediated apoptotic pathway involving caspase activation.
- No detectable toxicity was observed in normal tissues with rapidly dividing cells.
Conclusions:
- EM011 demonstrates potent anticancer activity against hormone-refractory prostate cancer with skeletal metastasis.
- The compound's mechanism involves cell-cycle blockade and induction of apoptosis via mitochondrial and caspase pathways.
- EM011 exhibits a favorable safety profile, warranting further clinical investigation for prostate cancer management.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
The Intrinsic Apoptotic Pathway
Destabilization of Microtubules
Microtubule Instability
Caspases